Pharma giant claims jobs at risk as court hears rival attempting to sell much cheaper generic version of drug

A rival of pharmaceutical giant Merck Sharp and Dohme (MSD) is trying to sell a generic version of a cholesterol drug for less than one tenth of the price of its product in breach of patent rights, it has been claimed in court proceedings.

Pharma giant claims jobs at risk as court hears rival attempting to sell much cheaper generic version of drug

By Ann O'Loughlin

A rival of pharmaceutical giant Merck Sharp and Dohme (MSD) is trying to sell a generic version of a cholesterol drug for less than one tenth of the price of its product in breach of patent rights, it has been claimed in court proceedings.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited